chr2-48646648-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000403751.8(GTF2A1L):āc.584A>Gā(p.Gln195Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000279 in 1,614,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000403751.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GTF2A1L | NM_006872.5 | c.584A>G | p.Gln195Arg | missense_variant | 6/9 | ENST00000403751.8 | NP_006863.2 | |
STON1-GTF2A1L | NM_001198593.2 | c.2696A>G | p.Gln899Arg | missense_variant | 8/11 | NP_001185522.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GTF2A1L | ENST00000403751.8 | c.584A>G | p.Gln195Arg | missense_variant | 6/9 | 1 | NM_006872.5 | ENSP00000384597 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 248848Hom.: 0 AF XY: 0.0000297 AC XY: 4AN XY: 134696
GnomAD4 exome AF: 0.0000280 AC: 41AN: 1461870Hom.: 0 Cov.: 33 AF XY: 0.0000206 AC XY: 15AN XY: 727232
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.584A>G (p.Q195R) alteration is located in exon 6 (coding exon 6) of the GTF2A1L gene. This alteration results from a A to G substitution at nucleotide position 584, causing the glutamine (Q) at amino acid position 195 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at